15-67191959-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005902.4(SMAD3):​c.*1423C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.223 in 228,792 control chromosomes in the GnomAD database, including 6,983 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3822 hom., cov: 32)
Exomes 𝑓: 0.26 ( 3161 hom. )

Consequence

SMAD3
NM_005902.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.848

Publications

16 publications found
Variant links:
Genes affected
SMAD3 (HGNC:6769): (SMAD family member 3) The SMAD family of proteins are a group of intracellular signal transducer proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. The SMAD3 protein functions in the transforming growth factor-beta signaling pathway, and transmits signals from the cell surface to the nucleus, regulating gene activity and cell proliferation. This protein forms a complex with other SMAD proteins and binds DNA, functioning both as a transcription factor and tumor suppressor. Mutations in this gene are associated with aneurysms-osteoarthritis syndrome and Loeys-Dietz Syndrome 3. [provided by RefSeq, May 2022]
SMAD3 Gene-Disease associations (from GenCC):
  • aneurysm-osteoarthritis syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 15-67191959-C-T is Benign according to our data. Variant chr15-67191959-C-T is described in ClinVar as Benign. ClinVar VariationId is 316902.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.448 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMAD3NM_005902.4 linkc.*1423C>T 3_prime_UTR_variant Exon 9 of 9 ENST00000327367.9 NP_005893.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMAD3ENST00000327367.9 linkc.*1423C>T 3_prime_UTR_variant Exon 9 of 9 1 NM_005902.4 ENSP00000332973.4

Frequencies

GnomAD3 genomes
AF:
0.201
AC:
30632
AN:
152034
Hom.:
3821
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0739
Gnomad AMI
AF:
0.211
Gnomad AMR
AF:
0.316
Gnomad ASJ
AF:
0.331
Gnomad EAS
AF:
0.462
Gnomad SAS
AF:
0.287
Gnomad FIN
AF:
0.181
Gnomad MID
AF:
0.285
Gnomad NFE
AF:
0.222
Gnomad OTH
AF:
0.238
GnomAD4 exome
AF:
0.265
AC:
20294
AN:
76642
Hom.:
3161
Cov.:
0
AF XY:
0.264
AC XY:
9370
AN XY:
35450
show subpopulations
African (AFR)
AF:
0.0743
AC:
271
AN:
3646
American (AMR)
AF:
0.312
AC:
736
AN:
2356
Ashkenazi Jewish (ASJ)
AF:
0.335
AC:
1603
AN:
4780
East Asian (EAS)
AF:
0.477
AC:
5179
AN:
10862
South Asian (SAS)
AF:
0.300
AC:
196
AN:
654
European-Finnish (FIN)
AF:
0.146
AC:
69
AN:
472
Middle Eastern (MID)
AF:
0.287
AC:
131
AN:
456
European-Non Finnish (NFE)
AF:
0.226
AC:
10628
AN:
47012
Other (OTH)
AF:
0.231
AC:
1481
AN:
6404
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
694
1388
2082
2776
3470
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.201
AC:
30652
AN:
152150
Hom.:
3822
Cov.:
32
AF XY:
0.206
AC XY:
15350
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.0739
AC:
3066
AN:
41510
American (AMR)
AF:
0.317
AC:
4841
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.331
AC:
1149
AN:
3468
East Asian (EAS)
AF:
0.463
AC:
2399
AN:
5180
South Asian (SAS)
AF:
0.286
AC:
1379
AN:
4816
European-Finnish (FIN)
AF:
0.181
AC:
1915
AN:
10570
Middle Eastern (MID)
AF:
0.286
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
0.222
AC:
15122
AN:
67994
Other (OTH)
AF:
0.239
AC:
505
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1202
2405
3607
4810
6012
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
342
684
1026
1368
1710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.184
Hom.:
470
Bravo
AF:
0.207
Asia WGS
AF:
0.337
AC:
1171
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Loeys-Dietz syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aneurysm-osteoarthritis syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.55
DANN
Benign
0.41
PhyloP100
-0.85
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2278670; hg19: chr15-67484297; API